News

San Antonio Hub To Foster Pediatric Medical Device Development

By Iris Gonzalez, Startups San Antonio The San Antonio-Austin hub of a pediatric medical device consortium ...

InCube, VelocityTX Join Work to Develop Pediatric Medical Devices

By David Holley, Xconomy Texas San Antonio—A group of San Antonio institutions are getting involved ...

News
CTRC patients enrolled in GenSpera cancer drug trial San Antonio Business Journal
March 28, 2011

The Cancer Therapy & Research Center has enrolled its first patient in a Phase 1 clinical trial using GenSpera's new G-202 chemotherapeutic agent.

Cancer drug company GenSpera Inc. said Monday that the first patient received a dosage of the company's experimental drug, G-202, at the Cancer Therapy & Research Center at the University of Texas Health Science Center at San Antonio.

San Antonio-based GenSpera (OTCBB: GNSZ) is conducting Phase 1 clinical trials at the University of Wisconsin Carbone Cancer Center and now the CTRC.

 

Stay informed. Subscribe to BioMed SA news alerts.